Today, it’s the DDP-4 inhibitors! DPP-4 inhibitors can be expensive which may limit their use from time to time. These drugs work to increase the amount of incretin in the body. You can look back at my post on Byetta/Victoza which should be under the diabetes...
I’m going to flip back to oral diabetes meds to cover a new agent that has recently been approved. It is a new class of diabetes med, but generally means it’s going to be quite expensive. This drug is Invokana (canagliflozin). It basically lowers glucose by causing an...
Thanks to Sarah Taylor, Pharm.D. for her guest post tonight! Sliding scale insulin, or SSI, is commonly seen in nursing homes, however, it might suprise most healthcare workers to hear that this form of diabetes “management” is not considered best...
The TZD’s or the thiazolinawhachamacallits…Avandia (rosiglitizone) is the bad boy on the block that no one typically uses anymore due to potential issues with heart failure. Actos (pioglitazone) is nearly always the one that gets used if a TZD is indicated. Primary...
Victoza and Byetta have a similar mechanism of action, and actually we can compare these to the DDP-4 inhibitors as well. These drugs are GLP-1 analogs which is similar to an incretin hormone in the body. Per Lexi-comp, incretin increases glucose-dependent insulin...
